Longitudinal analyses of subsequent samples derived from progressive disease stages of the same patient allowed for the appraisal of tumor evolution that mainly involved the acquisition of mutations in TP53 and in genes playing a role in chromatin remodeling, DNA repair, and epigenetic modulation. The gene discussed is TP53; the disease is neoplasm.